• By end user, the market is segmented into pharmaceutical and biotechnology
companies, contract research organizations, academic research institutes, and
other end users. Other end user segment primarily includes cell banks, small cell
culture laboratories and consultants, microbiology laboratories, immunology
laboratories, molecular laboratories, animal facilities, toxicology laboratories, and
media/sera manufacturers.
• The application segments included in this report are blood & blood products,
cellular & gene therapy products, stem cell products, tissue & tissue products,
and vaccines and therapeutics. Of these the vaccines and therapeutics application
hold the highest share.
• The geographic segments included in this report are Asia, Europe, North America,
and the Rest of the World (RoW). The North America segment is further divided
into Canada and the U.S. Asia segment is further divided into China, Japan, India,
and Rest of Asia.
https://www.marketsandmarkets.com/Market-Reports/viral-inactivation-market-121427017.html